Enanta
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Enanta and other ETFs, options, and stocks.About ENTA
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases.
ENTA Key Statistics
Stock Snapshot
As of today, Enanta(ENTA) shares are valued at $13.16. The company's market cap stands at 383M, with a P/E ratio of -5.46.
On 2026-08-16, Enanta(ENTA) stock traded between a low of $12.97 and a high of $13.38. Shares are currently priced at $13.16, which is +1.5% above the low and -1.6% below the high.
The Enanta(ENTA)'s current trading volume is 173.4K, compared to an average daily volume of 183.52K.
In the last year, Enanta(ENTA) shares hit a 52-week high of $17.15 and a 52-week low of $7.05.
In the last year, Enanta(ENTA) shares hit a 52-week high of $17.15 and a 52-week low of $7.05.
ENTA News
Enanta Pharmaceuticals (ENTA) has disclosed a new risk, in the Regulation category. Unlock powerful investing tools with TipRanks Premium to make smarter, more...
...
Reports Q3 revenue $14.4M, consensus $16.8M. “During the quarter, we continued to build momentum across both our RSV and immunology programs,” said Jay R. Luly,...
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.